No results were found for the filter!
B2M HLA-A*01:01 Lentivirus
Item number: BPS-82423
B2M HLA-A*01:01 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses result in the expression of B2M (beta-2 microglobulin) HLA (human leukocyte antigen)-A*01:01 driven by an EF1a...
| Keywords: | CDABP0092, |
| Application: | Protein expression, cell pool/stable cell line generation (puromycin selection) |
| Species reactivity: | human |
1,307.00€
*
B2M HLA-A*02:01 Lentivirus
Item number: BPS-82424
B2M HLA-A*02:01 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses result in the expression of B2M (beta-2 microglobulin) HLA (human leukocyte antigen)-A*02:01 driven by an EF1a...
| Keywords: | CDABP0092, |
| Application: | Protein expression, cell pool/stable cell line generation (puromycin selection) |
| Species reactivity: | human |
1,174.00€
*
B2M HLA-A*03:01 Lentivirus
Item number: BPS-82425
B2M HLA-A*03:01 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses result in the expression of B2M (beta-2 microglobulin) HLA (human leukocyte antigen)-A*03:01 driven by an EF1a...
| Keywords: | CDABP0092, |
| Application: | Protein expression, cell pool/stable cell line generation (puromycin selection) |
| Species reactivity: | human |
1,321.00€
*
B2M HLA-B*15:10 Lentivirus
Item number: BPS-82430
B2M HLA-B*15:10 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses result in the expression of B2M (beta-2 microglobulin) HLA (human leukocyte antigen)-B*15:10 driven by an EF1a...
| Keywords: | CDABP0092, |
| Application: | Protein expression, cell pool/stable cell line generation (puromycin selection) |
| Species reactivity: | human |
1,321.00€
*
B2M HLA-B*35:01 Lentivirus
Item number: BPS-82431
B2M HLA-B*35:01 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses result in the expression of B2M (beta-2 microglobulin) HLA (human leukocyte antigen)-B*35:01 driven by an EF1a...
| Keywords: | CDABP0092, |
| Application: | Protein expression, cell pool/stable cell line generation (puromycin selection) |
| Species reactivity: | human |
1,321.00€
*
Expanded Human Peripheral Blood Gamma Delta T Cells...
Item number: BPS-82443
Expanded Human Peripheral Blood Gamma Delta T Cells (Vdelta1), Frozen, are primary Vdelta1 T cells enriched and expanded from human PBMCs (Peripheral Blood Mononuclear Cells) using Membrane Bound IL-15 Based Growth-Arrested Feeder Cells (#82374), and cryopreserved. Expanded Human Peripheral Blood Gamma Delta T Cells...
| Keywords: | T cell receptor delta constant, |
| Application: | in vitro assays, cancer studies, cytotoxicity assays, drug screening, immune activation assays |
| Species reactivity: | human |
640.00€
*
Firefly Luciferase GPC3 CHO Cell Line
Item number: BPS-82489
Firefly Luciferase GPC3 CHO Cell Line is a CHO-K1 cell line that expresses the firefly luciferase reporter and constitutively expresses human GPC3 (Glypican 3) (Genbank# NM_004484.2). This cell line has been validated by flow cytometry and luciferase activity.
| Keywords: | GPC3, OCI5, |
| Application: | CAR-T / NK co-culture killing assay target cell, in vitro/in vivo bioluminescence imaging |
| Species reactivity: | human |
12,165.00€
*
Firefly Luciferase HepG2 Cell Line
Item number: BPS-82490
Firefly Luciferase HepG2 Cell Line is a liver cancer HepG2 cell line that expresses the firefly luciferase reporter driven by an EF1a promoter. This cell line has been generated by transduction with Firefly Luciferase Lentivirus (EF1A Promoter/ Hygromycin) (BPS Bioscience #78740-H). This cell line has been validated...
| Keywords: | Luciferase, Luciferin 4-monooxygenase, |
| Application: | CAR-T / NK co-culture killing assay target cell, in vitro/in vivo bioluminescence imaging |
| Species reactivity: | common eastern firefly |
3,271.00€
*
Anti-GPC3 CAR-T Cells
Item number: BPS-82492
Anti-GPC3 CAR-T Cells are produced by high-titer lentiviral transduction of human primary CD4+ and CD8+ T cells using Anti-GPC3 CAR Lentivirus (Clone GC33-CD28TM-41BB-CD3zeta) (BPS Bioscience #82494). These ready-to-use CAR-T cells express an anti-GPC3 (glypican-3) CAR (chimeric antigen receptor) consisting of the...
| Keywords: | GPC3, OCI5, |
| Application: | Positive control, modulator screening, co-culture cytotoxicity assay design/optimization |
| Species reactivity: | human |
2,569.00€
*
Anti-GPC3 CAR Lentivirus (Clone GC33-CD28TM-41BB-CD3zeta)
Item number: BPS-82494
Anti-GPC3 CAR Lentivirus (Clone GC33-CD28TM-41BB-CD3zeta) are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles ready to transduce all types of mammalian cells, including primary and non-dividing cells. These viruses transduce the ScFv portion of anti-GPC3 (glypican 3) (clone GC33) linked to...
| Keywords: | GPC3, OCI5, |
| Application: | Positive control, transduction optimization, anti-GPC3 CAR-T cell generation |
| Species reactivity: | human |
1,853.00€
*
HER2 Knockout MCF7 Cell Line
Item number: BPS-82857
HER2 Knockout MCF7 Cell Line is an MCF7 cell line in which human HER2 (Receptor tyrosine-protein kinase ErbB-2) has been genetically removed using CRISPR/Cas9 genome editing with a lentivirus encoding the CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human HER2. This cell line has been validated by...
| Keywords: | HER2, ERBB2, CD340, MLN 19, p185erbB2, EC=2.7.10.1, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Metastatic lymph node... |
| Application: | HER2 knockout impact studies, anti-HER2 CAR-T killing assay development control |
| Species reactivity: | human |
7,213.00€
*
CD38 Knockout A549 Cell Line
Item number: BPS-82953
CD38 Knockout A549 Cell Line is a A549 lung cancer cell line in which human CD38 (Cluster of Differentiation 38) has been genetically removed using CRISPR/Cas9 genome editing with a lentivirus encoding the CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human CD38.
| Keywords: | T10, CD38, ADPRC 1, cADPR hydrolase 1, ADP-ribosyl cyclase 1, Cyclic ADP-ribose hydrolase 1, 2'-phospho-ADP-ribosyl... |
| Application: | Negative control, CD38 knockout phenotype studies |
| Species reactivity: | human |
7,213.00€
*